Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

As the U.N.'s climate summit, COP29, gets underway in Azerbaijan this week, the effect of climate change on human health is ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

The coronavirus (COVID-19) changed various aspects of societal functions. For some time, it stripped people of social ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...